Bayer stock slides as Roundup settlement bounce fades; investors eye March 4 update
Bayer shares dropped 8.1% to 45.33 euros in Frankfurt after the company proposed a $7.25 billion settlement to resolve U.S. Roundup lawsuits. The plan would raise litigation liabilities to 11.8 billion euros and require about 5 billion euros in payouts in 2026. Bayer secured an $8 billion loan for immediate needs. The settlement still requires court approval and sufficient claimant participation.